Elevance Health, Inc.
ELV- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- SEC CIK
- 0001156039
Insider trades, last 90 days
2 buys · 0 sells
- Bought $1.37M
- Open-market purchases (P) and sales (S), counted by Form 4 filing.
13F holders, Q2 2026
1,614
- +141 vs. Q1 2026
- Total value $78.61B
Superinvestors holding ELV
2
- At the end of Q2 2026
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by ELV insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Jul 17, 20263:04 PM ET | Jul 17, 2026 | PERU RAMIRO GDirector | PPurchaseCommon Stock | +1K | $366.05 | +$366.05K | 10.91K | +10.1% | SEC |
| Jul 17, 20261:50 PM ET | Jul 17, 2026 | BOUDREAUX GAILPresident and CEO | PPurchaseCommon Stock | +2.73K | $367.7908 | +$1M | 171.98K | +1.6% | SEC |
| Jun 15, 2026 | Jun 12, 2026 | Penczek Ronald WCAO & Controller | SSaleCommon Stock | −369 | $403.16 | −$148.77K | 3.74K | −9.0% | SEC |
| Jun 12, 2026 | Jun 11, 2026 | Dixon Robert L JRDirector | SSaleCommon Stock | −151 | $401.77 | −$60.67K | 10.73K | −1.4% | SEC |
| May 20, 2026 | May 19, 2026 | Penczek Ronald WCAO & Controller | SSaleCommon Stock | −1.53K | $403.13 | −$617.19K | 4.11K | −27.1% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in ELV at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 18,991,090 | $7.34B | 0.11% | −896,021−4.5% | Reduced |
| VANGUARD CAPITAL MANAGEMENT LLC | 14,058,204 | $5.44B | 0.12% | −287,255−2.0% | Reduced |
| STATE STREET CORP | 10,426,610 | $4.03B | 0.12% | +137,914+1.3% | Added |
| WELLINGTON MANAGEMENT GROUP LLP | 9,213,513 | $3.56B | 0.61% | +984,976+12.0% | Added |
| First Eagle Investment Management, LLC | 8,376,392 | $3.24B | 2.68% | +4,244,101+102.7% | Added |